Let's not kid ourselves; the proceeds are needed to pay the massively inflated salaries of their top management. There are only 2 open positions advertised on their website. The amount they are being compensated for the revenues generated is a shame. It has been a long time since their first product received approval and there has been no significant increase in revenues. I doubt they have any competitive advantage over other non-H1N1 tests that will change their revenue stream. That PSA article was generated by Mirkin who is a board member, and the MD who was the co-author worked in Mirkin's lab. Not really credible in the absence of any clinical trials data.